We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+13.16%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
–
AUM
$14.9B
AUM Growth
+$995M
Cap. Flow
-$291M
Cap. Flow %
-1.95%
Top 10 Hldgs %
26.38%
Holding
2,856
New
31
Increased
336
Reduced
1,500
Closed
71

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$128M
2
LTHM
Livent Corporation
LTHM
+$15M
3
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$12.3M
4
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$12.2M
5
P
Everpure Inc
P
+$7.04M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$28.4M
2
MSFT icon
Microsoft
MSFT
+$25.6M
3
NVDA icon
NVIDIA
NVDA
+$15.2M
4
AMZN icon
Amazon
AMZN
+$11.2M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$10.9M

Sector Composition

Rank Sector Weight
1 Technology 27.53%
2 Financials 12.17%
3 Healthcare 11.68%
4 Consumer Discretionary 10.99%
5 Industrials 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EWTX icon
1626
Edgewise Therapeutics
EWTX
$4.69B
$546K ﹤0.01%
29,935
+6,580
+28% +$105K
TRS icon
1627
TriMas Corp
TRS
$1.41B
$546K ﹤0.01%
20,417
-1,669
-8% -$41.7K
PDFS icon
1628
PDF Solutions
PDFS
$2.19B
$545K ﹤0.01%
16,194
– –
ALKT icon
1629
Alkami Technology
ALKT
$2.22B
$543K ﹤0.01%
22,104
– –
IMKTA icon
1630
Ingles Markets
IMKTA
$1.66B
$542K ﹤0.01%
7,062
-470
-6% -$37.6K
PRTA icon
1631
Prothena Corp
PRTA
$466M
$541K ﹤0.01%
21,852
– –
AAT
1632
American Assets Trust
AAT
$1.41B
$541K ﹤0.01%
24,693
– –
OCUL icon
1633
Ocular Therapeutix
OCUL
$2.22B
$540K ﹤0.01%
59,333
+18,685
+46% +$133K
VSEC icon
1634
VSE Corp
VSEC
$6.81B
$539K ﹤0.01%
6,732
– –
PUBM icon
1635
PubMatic
PUBM
$783M
$538K ﹤0.01%
22,685
– –
CRAI icon
1636
CRA International
CRAI
$1.07B
$538K ﹤0.01%
3,595
– –
FLNC icon
1637
Fluence Energy
FLNC
$2.44B
$532K ﹤0.01%
30,655
– –
CGON icon
1638
CG Oncology
CGON
$6.62B
$531K ﹤0.01%
+12,106
New +$494K
QCRH icon
1639
QCR Holdings
QCRH
$1.73B
$531K ﹤0.01%
8,748
– –
RCUS icon
1640
Arcus Biosciences
RCUS
$3.67B
$531K ﹤0.01%
28,134
– –
ANIP icon
1641
ANI Pharmaceuticals
ANIP
$1.72B
$531K ﹤0.01%
7,676
– –
BHE icon
1642
Benchmark Electronics
BHE
$2.94B
$527K ﹤0.01%
17,576
-2,187
-11% -$63.1K
LGF.B
1643
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$527K ﹤0.01%
56,645
-4,580
-7% -$42.4K
BLBD icon
1644
Blue Bird Corp
BLBD
$2.04B
$527K ﹤0.01%
13,742
+447
+3% +$13.7K
PEBO icon
1645
Peoples Bancorp
PEBO
$1.48B
$527K ﹤0.01%
17,790
– –
SAFE
1646
Safehold
SAFE
$1.1B
$526K ﹤0.01%
25,513
– –
PRAA icon
1647
PRA Group
PRAA
$762M
$525K ﹤0.01%
20,146
– –
BBT
1648
Beacon Financial Corp
BBT
$2.71B
$525K ﹤0.01%
22,916
– –
WMK icon
1649
Weis Markets
WMK
$1.78B
$525K ﹤0.01%
8,147
-648
-7% -$40.5K
SRRK icon
1650
Scholar Rock
SRRK
$6.46B
$521K ﹤0.01%
29,324
– –
64 65
66
67 68

Similar funds

BA
Bridgewater Associates Westport, Connecticut $22.4B AUM 34.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

MetLife Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, MetLife Investment Management held 2,856 positions worth $14.9B, up 7.2% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3.6%. MetLife Investment Management opened 31 new positions and exited 71, leaving the 2,856-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q1 2024 buy was Flutter Entertainment: 9,898 shares worth $1.98M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $128M increase.
  • MetLife Investment Management's biggest Q1 2024 reduction was Apple, cutting an estimated $28.4M.
  • MetLife Investment Management fully exited Immunogen Inc in Q1 2024, selling an estimated $3.72M.
  • MetLife Investment Management's ten largest holdings make up 26% of its $14.9B portfolio in Q1 2024.
  • MetLife Investment Management opened 31 new positions and closed 71 in Q1 2024.
  • MetLife Investment Management's portfolio value rose 7.2% quarter-over-quarter to $14.9B.

Based on MetLife Investment Management's 13F filing for Q1 2024, filed 14 May 2024.